These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2033687)

  • 21. Intracavernosal injection of pharmacological agents in the diagnosis and treatment of impotence.
    Siraj QH; Akhtar MA
    J Pak Med Assoc; 1989 Jul; 39(7):172-6. PubMed ID: 2504962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of visual sexual stimuli and apomorphine SL on cerebral activity in men with erectile dysfunction.
    Hagemann JH; Berding G; Bergh S; Sleep DJ; Knapp WH; Jonas U; Stief CG
    Eur Urol; 2003 Apr; 43(4):412-20. PubMed ID: 12667723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Septohippocampal cholinergic pathway and penile erections induced by dopaminergic and cholinergic stimulants.
    Maeda N; Matsuoka N; Yamaguchi I
    Brain Res; 1990 Dec; 537(1-2):163-8. PubMed ID: 1982238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nocturnal erectile activity in erectile dysfunction. An examination of nocturnal penile tumescence and rigidity].
    Poulsen EU; Kirkeby HJ
    Ugeskr Laeger; 1989 Jan; 151(2):81-3. PubMed ID: 2911901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
    Sidi AA; Cameron JS; Duffy LM; Lange PH
    J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain activation patterns during video sexual stimulation following the administration of apomorphine: results of a placebo-controlled study.
    Montorsi F; Perani D; Anchisi D; Salonia A; Scifo P; Rigiroli P; Deho F; De Vito ML; Heaton J; Rigatti P; Fazio F
    Eur Urol; 2003 Apr; 43(4):405-11. PubMed ID: 12667722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury].
    Momose H; Natsume O; Yamamoto M; Suemori T; Yamada K
    Hinyokika Kiyo; 1987 Jul; 33(7):1065-9. PubMed ID: 3687629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study.
    Wessells H; Fuciarelli K; Hansen J; Hadley ME; Hruby VJ; Dorr R; Levine N
    J Urol; 1998 Aug; 160(2):389-93. PubMed ID: 9679884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of erectile dysfunction with continuous monitoring of penile rigidity.
    Kaneko S; Bradley WE
    J Urol; 1986 Nov; 136(5):1026-9. PubMed ID: 3773061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation and treatment of sexual dysfunction in men with diabetes mellitus.
    Murray FT; Geisser ME; Cohen MS; Williams RS
    J Fla Med Assoc; 1991 Nov; 78(11):757-61. PubMed ID: 1765757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose.
    Stark S; Sachse R; Liedl T; Hensen J; Rohde G; Wensing G; Horstmann R; Schrott KM
    Eur Urol; 2001 Aug; 40(2):181-8; discussion 189-90. PubMed ID: 11528196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apomorphine: an update of clinical trial results.
    Heaton JP
    Int J Impot Res; 2000 Oct; 12 Suppl 4():S67-73. PubMed ID: 11035390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infusion pharmacocavernosometry and nocturnal penile tumescence findings in men with erectile dysfunction.
    Montague DK; Lakin MM; VanderBurg Mendendorp S; Tesar LJ
    J Urol; 1991 Apr; 145(4):768-71. PubMed ID: 2005697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of sexual history to differentiate organic from psychogenic impotence.
    Segraves KA; Segraves RT; Schoenberg HW
    Arch Sex Behav; 1987 Apr; 16(2):125-37. PubMed ID: 3592960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Initial experiences with prostaglandin E1 and PGE1 prepared injections].
    Mattarelli G; Leibundgut B
    Helv Chir Acta; 1991 Sep; 58(3):335-7. PubMed ID: 1769856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
    Lee LM; Stevenson RW; Szasz G
    J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
    Bratus D; Hlebic G; Hajdinjak T
    Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
    Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
    J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trial of pentoxifylline for diabetic impotence.
    Georgitis WJ; Merenich JA
    Diabetes Care; 1995 Mar; 18(3):345-52. PubMed ID: 7555478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Apomorphine and erectile dysfunction].
    Tan DQ; Yao Y; Zhang J
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.